HQ Team
July 22, 2026: The United States has recorded 2,295 measles cases, the highest total in 35 years. The raw number is alarming, but more importantly, it is how these cases are appearing: not only in traditionally under-vaccinated pockets, but spilling into states and cities that, on paper, meet the 95% MMR threshold associated with herd immunity.
This paradox exposes a fragile reality: statewide averages mask local vulnerability, and when measles meets a concentrated pocket of under-vaccinated people, outbreaks happen.
The current wave began as a West Texas outbreak in January 2025 before leaping state lines. Already, 2,104 cases have been reported in just the first half of this year.
Immunization rates are tracked through school vaccinations. Nationally, that number has hovered around 92% in recent years, but in many pockets around the country, it’s now well below 80%, which leaves communities open to large outbreaks.
The current wave has three clear drivers: slipping vaccination coverage among children, highly clustered under-vaccination in tight-knit communities, and repeated importations from abroad. Add weakened public-health capacity after the pandemic, a persistent misinformation ecosystem, anti vaccine beliefs, and the conditions for sustained transmission are in place.
What the numbers show
Total cases in 2026: 2,295 (through July 22)
Outbreaks: 34 declared; 93% of cases tied to outbreaks
Age breakdown: children under 5 — 20%;
ages 5–19 — 50%
adults 20+ — 30%
Hospitalizations: ~6% of cases (about 146 people)
Deaths: none reported in 2026 (three deaths in 2025)
Measles remains a childhood disease that spreads quickly through schools and social networks; half of cases are among school-age children. Second, the presence of adult cases shows immunity gaps in older cohorts that were either never vaccinated or whose immunity has waned or was never fully developed.
Why “>95%” doesn’t guarantee safety.
Herd immunity is a useful benchmark, but it’s blunt. A statewide MMR coverage of 95% can give a false sense of security when unvaccinated people cluster together.
CDC modeling shows how sensitive outbreak risk is to these gaps: at 95% coverage, the risk of an outbreak is still roughly 29%; at 90%, it jumps to about 51%. In other words, local concentration of susceptible individuals overrides statewide protection. New York City, despite reporting ~97% coverage, has experienced outbreaks tied to specific communities with far lower vaccination rates — a pattern we now see across the country.
How the U.S. compares and what others do differently?
Other high‑income countries facing measles challenges have leaned on three tactics the U.S. has been slower to deploy at scale: stronger school-entry mandates, aggressive catch-up vaccination campaigns, and centralized surveillance.
Europe (EU/EEA): Countries like Italy and France have used mandatory vaccination policies for school entry and nationwide catch-up efforts. Where implemented vigorously, these policies reduce the size and frequency of outbreaks.
Australia & UK: Both have debated or implemented “no jab, no school”–style measures, backed by penalties or barriers to noncompliance, increasing uptake in critical age groups.
Asia: In Asia, most countries maintain strict government-mandated vaccine policies. Wealthier Asian nations like Japan rely on antibody testing for adults and two-dose schedules for children, while developing nations like India rely on door-to-door mass campaigns.
The MMR vaccine is routinely administered to newborns and the first dose is given between 9 to 12 months and the second dose at 12 to 18 months.
The U.S., by contrast, runs on a patchwork of state laws that allow exemptions (medical, and in many states, religious or philosophical). That fragmentation, combined with active vaccine hesitancy and the political polarization of public health measures, creates fertile ground for measles to reestablish footholds.
Practical policy steps that would reduce risk
Targeted catch-up campaigns: Rapid, community-tailored vaccination drives in neighborhoods and schools showing low coverage. Blanket messaging misses clustered pockets; targeted outreach does not.
Strengthen school-entry requirements and limit nonmedical exemptions: Evidence shows mandates tied to school entry are among the most effective levers to raise coverage quickly.
Improve surveillance and outbreak response capacity: Fund local health departments to perform contact tracing, deploy mobile vaccination clinics, and maintain vaccine stockpiles.
Adult immunity checks: Incorporate MMR status checks into routine adult care and workplace health programs for high-risk settings (healthcare, education).
Counter misinformation with local messengers: Use trusted community leaders and clinicians to address fears and practical barriers to vaccination rather than rely solely on national campaigns.
A preventable rebound
Measles is no longer endemic in the U.S.; elimination was a public-health milestone. But elimination is fragile. The current resurgence may again put it back in the non-endemic category with a regulatory review scheduled for November.
“Elimination is a specific defined thing. It’s not just a number of cases or a vibe,” said Dr. Jake Scott, an infectious disease expert at Stanford. “The reason a lot of us are saying that we’ve effectively lost elimination status is that the virus has been spreading person-to-person here, across multiple states, for more than a year without a clean break since Texas. We’re past the line (of elimination). But the official call doesn’t come until November.”
If the goal is to restore and sustain elimination, policy must pivot from passive encouragement to strategic, equity‑focused action
